Design and fabrication of electrochemical energy storage systems with both high energy and power densities as well as long cycling life is of great importance. As one of these systems, Battery‐supercapacitor hybrid device (BSH) is typically constructed with a high‐capacity battery‐type electrode and a high‐rate capacitive electrode, which has attracted enormous attention due to its potential applications in future electric vehicles, smart electric grids, and even miniaturized electronic/optoelectronic devices, etc. With proper design, BSH will provide unique advantages such as high performance, cheapness, safety, and environmental friendliness. This review first addresses the fundamental scientific principle, structure, and possible classification of BSHs, and then reviews the recent advances on various existing and emerging BSHs such as Li‐/Na‐ion BSHs, acidic/alkaline BSHs, BSH with redox electrolytes, and BSH with pseudocapacitive electrode, with the focus on materials and electrochemical performances. Furthermore, recent progresses in BSH devices with specific functionalities of flexibility and transparency, etc. will be highlighted. Finally, the future developing trends and directions as well as the challenges will also be discussed; especially, two conceptual BSHs with aqueous high voltage window and integrated 3D electrode/electrolyte architecture will be proposed.

Iron oxides are promising to be utilized in rechargeable alkaline battery with high capacity upon complete redox reaction (Fe 3+ Fe 0 ). However, their practical application has been hampered by the poor structural stability during cycling, presenting a challenge that is particularly huge when binder-free electrode is employed. This paper proposes a "carbon shellprotection" solution and reports on a ferroferric oxide-carbon (Fe 3 O 4 -C) binder-free nanorod array anode exhibiting much improved cyclic stability (from only hundreds of times to >5000 times), excellent rate performance, and a high capacity of ≈7776.36 C cm −3 (≈0.4278 C cm

Considerable areal capacitance (mF cm(-2) level) and long cycling stability (2000 cycles, the best ever for Fe(3)O(4)-based electrodes) are demonstrated for the first time for Fe(3)O(4)@SnO(2) core-shell nanorod film, which is grown directly on a current collector substrate.

Sequence-to-sequence (seq2seq) approach for low-resource ASR is a relatively new direction in speech research. The approach benefits by performing model training without using lexicon and alignments. However, this poses a new problem of requiring more data compared to conventional DNN-HMM systems. In this work, we attempt to use data from 10 BABEL languages to build a multilingual seq2seq model as a prior model, and then port them towards 4 other BABEL languages using transfer learning approach. We also explore different architectures for improving the prior multilingual seq2seq model. The paper also discusses the effect of integrating a recurrent neural network language model (RNNLM) with a seq2seq model during decoding. Experimental results show that the transfer learning approach from the multilingual model shows substantial gains over monolingual models across all 4 BABEL languages. Incorporating an RNNLM also brings significant improvements in terms of %WER, and achieves recognition performance comparable to the models trained with twice more training data.

Electrodes with three-dimensional (3D) nanostructure are expected to improve the energy and power densities per footprint area of lithium ion microbatteries. Herein, we report a large-scale synthesis of a SnO(2)/α-Fe(2)O(3) composite nanotube array on a stainless steel substrate via a ZnO nanowire array as an in situ sacrificial template without using any strong acid or alkali. Importantly, both SnO(2) and α-Fe(2)O(3) contribute to the lithium storage, and the hybridization of SnO(2) and α-Fe(2)O(3) into an integrated nanotube structure provides them with an elegant synergistic effect when participating in electrochemical reactions. Large areal capacities and good rate capability are demonstrated for such a composite nanotube array. Particularly noteworthy is that the areal capacities (e.g. 1.289 mAh cm(-2) at a current rate of 0.1 mA cm(-2)) are much larger than those of many previous thin-film/3D microbattery electrodes. Our work suggests the possibility of further improving the areal capacity/energy density of 3D microelectrodes by designing ordered hybrid nanostructure arrays.

The cardiovascular safety of nonsteroidal antiinflammatory drugs (NSAIDs) may be influenced by interactions with antiplatelet doses of aspirin. We sought to quantitate precisely the propensity of commonly consumed NSAIDs-ibuprofen, naproxen, and celecoxib-to cause a drug-drug interaction with aspirin in vivo by measuring the target engagement of aspirin directly by MS. We developed a novel assay of cyclooxygenase-1 (COX-1) acetylation in platelets isolated from volunteers who were administered aspirin and used conventional and microfluidic assays to evaluate platelet function. Although ibuprofen, naproxen, and celecoxib all had the potential to compete with the access of aspirin to the substrate binding channel of COX-1 in vitro, exposure of volunteers to a single therapeutic dose of each NSAID followed by 325 mg aspirin revealed a potent drug-drug interaction between ibuprofen and aspirin and between naproxen and aspirin but not between celecoxib and aspirin. The imprecision of estimates of aspirin consumption and the differential impact on the ability of aspirin to inactivate platelet COX-1 will confound head-to-head comparisons of distinct NSAIDs in ongoing clinical studies designed to measure their cardiovascular risk.aspirin | acetylation | cyclooxygenase | MS | nonsteroidal antiinflammatory drugs C hronic pain, most commonly inflammatory musculoskeletal pain, afflicts hundreds of millions worldwide (1). Nonsteroidal antiinflammatory drugs (NSAIDs) consumed chronically or intermittently remain the mainstay of therapy for inflammationassociated pain. These agents inhibit cyclooxygenase (COX)-1 and COX-2, thereby reducing the production of inflammatory prostanoids, lipid mediators that lower the activation threshold of nociceptors and sensory neurons. The prevalence of chronic pain rises in the elderly, coinciding with an increase in concomitant disease (1), which complicates drug treatment. Pain management in patients with preexisting cardiovascular disease is a particular challenge because of the cardiovascular adverse effects of NSAIDs and the risk of drug-drug interactions that might undermine the antiplatelet effects of aspirin prescribed for cardioprotection (2).Although NSAIDs relieve pain effectively, they can cause serious renal and cardiovascular complications by inhibiting COXdependent prostanoids with homeostatic functions (3, 4). All NSAIDs have the potential to elevate blood pressure and may cause heart failure. COX-2-selective NSAIDs, which were developed to reduce gastrointestinal toxicity, additionally raise the rate of myocardial infraction and stroke (5, 6), affecting ∼1-2% of patients exposed per year (3,4). This adverse drug reaction may have caused thousands of deaths in the general population. Traditional NSAIDs (tNSAIDs) have also been associated with cardiovascular events, but although pharmacoepidemiological studies and metaanalyses of randomized, controlled trials suggest that not all tNSAIDs carry the same risk, there is considerable heterogeneity across studies in the comparative ...

Organic chemistry in aerosol water has recently been recognized as a potentially important source of secondary organic aerosol (SOA) material. This SOA material may be surface-active, therefore potentially affecting aerosol heterogeneous activity, ice nucleation, and CCN activity. Aqueous aerosol chemistry has also been shown to be a potential source of light-absorbing products ("brown carbon"). We present results on the formation of secondary organic aerosol material in aerosol water and the associated changes in aerosol physical properties from GAMMA (Gas-Aerosol Model for Mechanism Analysis), a photochemical box model with coupled gas and detailed aqueous aerosol chemistry. The detailed aerosol composition output from GAMMA was coupled with two recently developed modules for predicting a) aerosol surface tension and b) the UV-Vis absorption spectrum of the aerosol, based on our previous laboratory observations. The simulation results suggest that the formation of oligomers and organic acids in bulk aerosol water is unlikely to perturb aerosol surface tension significantly. Isoprene-derived organosulfates are formed in high concentrations in acidic aerosols under low-NO(x) conditions, but more experimental data are needed before the potential impact of these species on aerosol surface tension may be evaluated. Adsorption of surfactants from the gas phase may further suppress aerosol surface tension. Light absorption by aqueous aerosol SOA material is driven by dark glyoxal chemistry and is highest under high-NO(x) conditions, at high relative humidity, in the early morning hours. The wavelength dependence of the predicted absorption spectra is comparable to field observations and the predicted mass absorption efficiencies suggest that aqueous aerosol chemistry can be a significant source of aerosol brown carbon under urban conditions.

Background Coagulation factor deficiencies create a range of bleeding phenotypes. Microfluidic devices offer controlled hemodynamics and defined procoagulant triggers for measurement of clotting under flow. Objectives We tested a flow assay of contact pathway-triggered clotting to quantify platelet and fibrin deposition distal of dysfunctional thrombin production. Microfluidic metrics were then compared with PTT or % factor activity assays. Methods Whole blood (WB) treated with low level corn trypsin inhibitor (4 µg/ml) from 9 healthy donors and 27 patients [deficient in: Factor VIII (19 patients); IX (1); XI (1); VWF (6)] was perfused over fibrillar collagen at wall shear rate=100 s−1. Results Using healthy WB, platelets deposited within 30 sec, while fibrin appeared within 6 min. Compared to healthy controls, WB from patients displayed a 50% reduction in platelet deposition only at <1 % factor activity. In contrast, striking defects in fibrin deposition occurred for patients with <13% factor activity (or PTT >40 sec). Full occlusion of the 60-micron high channel was completely absent over the 15 min test in patients with <1% factor activity, while an intermediate defect was present in patients with >1% factor. Conclusion Spontaneous bleeding in patients with < 1% factor activity may be linked to deficits in both platelet and fibrin deposition, a risk known to be mitigated when factor levels are raised to >1 % activity (PTT of ~40–60 sec), a level that does not necessarily rescue fibrin formation under flow.